|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Operating expenses: | ||||
| Cost of revenue, excluding depreciation and amortization of intangible assets | ||||
| Research and development | ||||
| Selling, general and administrative | ||||
| Depreciation expense | ||||
| Amortization expense | ||||
| Impairment of long-lived assets | ||||
| Total operating expenses | ||||
| Operating loss | ||||
| Other (expense) income, net | ||||
| Interest and other income, net | ||||
| Interest expense - debt | ||||
| Total other (expense) income, net | ||||
| Gain on divestiture | ||||
| (Loss) income before taxes | ||||
| Provision for income taxes | ||||
| Net loss | ||||
| Less: net income (loss) attributable to noncontrolling interest | ||||
| Net loss attributable to the Company | ||||
| Loss per share attributable to the Company: | ||||
| Basic loss per share | ||||
| Diluted loss per share | ||||
| Weighted-average number of shares used in computing net loss per share attributable to the Company - basic | ||||
| Weighted-average number of shares used in computing net loss per share attributable to the Company - diluted | ||||
Loading...
